CoChat

United States Pharmacopeia Safety Evaluation of Spirulina

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Abstract

The Dietary Supplements Information Expert Committee (DSI-EC) of the United States Pharmacopeial Convention (USP) reviews the safety of dietary supplements and dietary supplement ingredients for the purpose of determining whether they should be admitted as quality monographs into the United States Pharmacopeia and National Formulary (USP-NF). The United States Food and Drug Administration (FDA) has enforcement authority to pursue a misbranding action in those instances where a dietary supplement product indicates that it conforms to USP standards but fails to so conform. Recently DSI-EC undertook a safety evaluation of spirulina, a widely used dietary ingredient. DSI-EC reviewed information from human clinical trials, animal studies, and regulatory and pharmacopeial sources and analyzed 31 adverse event reports regarding spirulina to assess potential health concerns. At the conclusion of this review, DSI-EC assigned a Class A safety rating for Spirulina maxima and S. platensis, thereby permitting the admission of quality monographs for these dietary supplement ingredients in USP-NF. DSI-EC continually monitors reports concerning the safety of dietary supplements and dietary supplement ingredients for which USP dietary supplement monographs are developed. The DSI-EC may revisit the safety classification of spirulina as new information on this dietary ingredient becomes available.

Overview

Integrity signals

Registry

Crossref · 10.1080/10408391003721719

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 72 references

Research works printed but not linked: 33

  1. Atwater J. B., 2003, Regul. Aff. Focus, 42
  2. Atwater J. B., 2005, U.S. Pharmacist., 30, 61
  3. Băiuş C., 2002, Rom. J. Intern. Med, 40, 89
  4. Blumenthal M., 2000, Commission E Monographs
  5. Brinker F., 2001, Herb Contraindications and Drug Interaction, 3rd Ed.
  6. Chamorro G., 1996, Toxicol. Lett., 88, 67
  7. Chamorro G., 1996, Rev. Invest. Clin, 48, 389
  8. 2009, Canada Vigilance Adverse Reaction Online Database
  9. 2009, Dietary Supplements Labels Database
  10. 1995, ICH Topic E2A: Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
  11. 2003, Agency Response Letter GRAS Notice No. GRN 000127
  12. 2007, Toxicological Principles for the Safety Assessment of Food Ingredients.
  13. 10.1001/jama.249.13.1743 · doi:10.1001/jama.249.13.1743 · Paper page
  14. 2008, Cyanobacterial Toxins: Microcystin-LR
  15. 2005, Dietary Supplements: A Framework for Evaluating Safety
  16. 10.1111/j.1572-0241.2002.07145.x · doi:10.1111/j.1572-0241.2002.07145.x · Paper page
  17. Johnson P. E., 1986, Nutr. Rep. Int., 34, 1063
  18. Karkos P. D., 2008, Evid. Based Complement. Alternat. Med.
  19. McGuffin M, 2000, Herbs of Commerce, 2nd Edition.
  20. 2009, Medicines and Healthcare products Regulatory Agency, UK
  21. 2009, Nutrition Business Journal; Raw material and ingredient supply report
  22. Taxonomy Browser
  23. 2009, National Library of Medicine. Medline Plus herbs and supplements—spirulina
  24. 2008, Chemical information review document for L-b-methylaminoalanine. Supporting nomination for toxicological evaluation by the National Toxicology Program
  25. 2001, Office of Inspector General Report: Adverse event reporting for dietary supplements: An inadequate safety valve
  26. 2008, Parry Nutraceuticals (India). Organic spirulina
  27. PubMed Database (available athttp://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed) (accessed 22 October 2009).
  28. 2007, Cyanosite
  29. Richmond A., 1999, J. Applied Physiol., 4, 281
  30. 2005, Therapeutic Goods Administration, Australia
  31. 2009, Admission Criteria and Safety Classification for Dietary Supplements Guideline
  32. 2004, World Health Organization Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems
  33. Yamani E., 2009, Med. Trop. (Mars)., 69, 66

Cited by

See all 177

Metadata

Authors
Marles, R. J., Barrett, M. L., Barnes, J., Chavez, M. L., Gardiner, P., Ko, R., Mahady, G. B., Dog, T. L., Sarma, N. D., Giancaspro, G. I., Sharaf, M., & Griffiths, J.
Affiliations
United States Pharmacopeial Convention (US)
Venue
Critical Reviews in Food Science and Nutrition
Published
2011-08
Volume
51
Issue
7
Pages
593-604
ISSN
  • 1040-8398 (ISSN-L)
  • 1549-7852
OpenAlex
W2004467604
Cited by
177
References
71
Citations by year
2026: 7 · 2025: 14 · 2024: 23 · 2023: 13 · 2022: 35 · 2021: 14 · 2020: 9 · 2019: 11 · 2018: 11 · 2017: 10 · 2016: 4 · 2015: 10 · 2014: 5 · 2013: 5 · 2012: 3
FWCI
12.81
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Reviews in Food Science and Nutrition (publishedVersion)
  • PubMed (publishedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
Funders
Purdue University
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Phytochemistry Medicinal Plant Applications
Keywords
Spirulina, Spirulina maxima, Spirulina platensis, supplement safety, adverse event reports, safety classification, misbranding, cyanobacteria
MeSH terms
Clinical Trials as Topic, Drug Evaluation, Drug Interactions, Humans, United States, United States Food and Drug Administration, Adverse Drug Reaction Reporting Systems, Guidelines as Topic, Metals, Heavy, Dietary Supplements, Microcystins, Spirulina

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: United States Pharmacopeia Safety Evaluation of Spirulina. https://app.cochat.ai/papers/10.1080/10408391003721719
The paper
Marles, R. J., Barrett, M. L., Barnes, J., Chavez, M. L., Gardiner, P., Ko, R., Mahady, G. B., Dog, T. L., Sarma, N. D., Giancaspro, G. I., Sharaf, M., & Griffiths, J. (2011). United States Pharmacopeia Safety Evaluation of Spirulina. Critical Reviews in Food Science and Nutrition. https://doi.org/10.1080/10408391003721719

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.